Aspirin Delayed-Release Capsules

» Aspirin Delayed-Release Capsules contain not less than 93.0 percent and not more than 107.0 percent of the labeled amount of aspirin (C9H8O4).

Packaging and storage— Preserve in tight containers.

Labeling— The label indicates that the Capsules or the contents thereof are enteric-coated.

USP Reference standards

—

USP Aspirin RS

USP Salicylic Acid RS

Identification—

A: Heat about 100 mg of the Capsule contents with 10 mL of water for several minutes, cool, and add 1 drop of ferric chloride TS: a violet-red color is produced.

B: Infrared Absorption

197K

—Prepare the test specimen as follows. Shake a quantity of the contents of Capsules, equivalent to about 500 mg of aspirin, with 10 mL of alcohol for several minutes. Centrifuge the mixture. Pour off the clear supernatant and evaporate it to dryness. Dry the residue in vacuum at 60

for 1 hour.

Dissolution

711

— Proceed as directed for Procedure for Method A under Apparatus 1 and Apparatus 2, Delayed-Release Dosage Forms.

Apparatus 1: 100 rpm.

Time: 90 minutes, for Buffer stage.

Diluent— Prepare a mixture of 0.1 N hydrochloric acid and 0.20 M tribasic sodium phosphate (3:1), and adjust, if necessary, with 2 N hydrochloric acid or 2 N sodium hydroxide to a pH of 6.8 ± 0.05.

Procedure— Determine the amount of C9H8O4 dissolved by determining UV absorbances at the wavelength of the isosbestic point of aspirin and salicylic acid (about 280 nm in the Acid stage, and about 265 nm in the Buffer stage), using a filtered portion of the solution under test, diluted, if necessary, with 0.1 N hydrochloric acid (analyzing the Acid stage) and with Diluent (analyzing the Buffer stage), in comparison with a Standard solution having a known concentration of USP Aspirin RS in the same medium.

Uniformity of dosage units

905

: meet the requirements.

Limit of free salicylic acid—

Mobile phase and Diluting solution— Prepare as directed in the Assay.

Standard solution— Dissolve an accurately weighed quantity of USP Salicylic Acid RS in the Standard preparation, prepared as directed in the Assay, to obtain a solution having a known concentration of about 0.015 mg of salicylic acid per mL.

Test solution— Use the Stock solution prepared as directed for Assay preparation.

Chromatographic system— Use the Chromatographic system described in the Assay. Chromatograph the Standard solution, and record the peak responses as directed for Procedure in the Assay: the relative retention times are about 0.7 for salicylic acid and 1.0 for aspirin; the resolution, R, between salicylic acid and aspirin is not less than 2.0; and the relative standard deviation of the salicylic acid peak responses is not more than 4.0%.

Procedure— Proceed as directed for Procedure in the Assay. Calculate the percentage of salicylic acid (C7H6O3) in the portion of Capsules taken by the formula:

2000(C / QA)(rU / rS)

in which C is the concentration, in mg per mL, of USP Salicylic Acid RS in the Standard solution; QA is the quantity, in mg, of aspirin (C9H8O4) in the portion of Capsules taken, as determined in the Assay; and rU and rS are the peak responses of the salicylic acid peaks obtained from the Test solution and the Standard solution, respectively: not more than 3.0% is found.

Assay—

Mobile phase— Dissolve 2 g of sodium 1-heptanesulfonate in a mixture of 850 mL of water and 150 mL of acetonitrile, and adjust with glacial acetic acid to a pH of 3.4.

Diluting solution— Prepare a mixture of acetonitrile and formic acid (99:1).

Standard preparation— Dissolve an accurately weighed quantity of USP Aspirin RS in Diluting solution to obtain a solution having a known concentration of about 0.5 mg per mL.

Assay preparation— Remove, as completely as possible, the contents of not fewer than 20 Capsules, and weigh accurately. Mix the combined contents, and transfer an accurately weighed quantity of the powder, equivalent to about 100 mg of aspirin, to a suitable container. Add 20.0 mL of Diluting solution and about 10 glass beads. Shake vigorously for about 10 minutes, and centrifuge (Stock solution). Quantitatively dilute an accurately measured volume of the Stock solution with 9 volumes of Diluting solution (Assay preparation). Retain the remaining portion of Stock solution for the test for Limit of free salicylic acid.

Chromatographic system (see Chromatography

621

)— The liquid chromatograph is equipped with a 280-nm detector and a 4.0-mm × 30-cm column containing packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not greater than 2.0; and the relative standard deviation is not more than 2.0%.

Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of aspirin (C9H8O4) in the portion of Capsules taken by the formula:

200C(rU / rS)

in which C is the concentration, in mg per mL, of USP Aspirin RS in the Standard preparation; and rU and rS are the peak responses of the aspirin peaks obtained from the Assay preparation and the Standard preparation, respectively.

Auxiliary Information— Please check for your question in the FAQs before contacting USP.

Topic/Question	Contact	Expert Committee
Monograph	Clydewyn M. Anthony, Ph.D. Senior Scientific Liaison 1-301-816-8139	(SM22010) Monographs - Small Molecules 2
Reference Standards	RS Technical Services 1-301-816-8129 rstech@usp.org
711	Margareth R.C. Marques, Ph.D. Senior Scientific Liaison 1-301-816-8106	(GCDF2010) General Chapters - Dosage Forms

USP35–NF30 Page 2247

Pharmacopeial Forum: Volume No. 31(1) Page 140